Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine.
about
Vaccines and antiviral drugs in pandemic preparednessAmantadine and rimantadine for influenza A in children and the elderlyAmantadine and rimantadine for influenza A in children and the elderlyAmantadine and rimantadine for influenza A in children and the elderlyAmantadine and rimantadine for influenza A in adultsAmantadine and rimantadine for preventing and treating influenza A in adultsEfficacy and safety of over-the-counter analgesics in the treatment of common cold and fluAssessment of the antiviral properties of recombinant porcine SP-D against various influenza A viruses in vitroComparison of a new neuraminidase detection assay with an enzyme immunoassay, immunofluorescence, and culture for rapid detection of influenza A and B viruses in nasal wash specimensInfluenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus.Health outcome and safety assessment of a fixed dose combination of Amantadine, Paracetamol, Chlorpheniramine maleate, and Phenylephrine introduction in India: A prescription event monitoring study.Antiviral therapy: current concepts and practicesInfluenza vaccination in the elderly.Adamantane-resistant influenza infection during the 2004-05 season.Treatment of acute bronchitis in adults without underlying lung disease.Control of influenza outbreaks in the nursing home: guidelines for diagnosis and management.Viral pneumonias. The increasing importance of a high index of suspicion.The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis
P2860
Q22305646-6B5ECC15-2386-449C-8AC2-19FB3F862A15Q24187883-9C2AEE71-8F13-4D0A-8A58-C5D1462DE8E1Q24203853-20A3DD9C-BABB-4287-9559-4C2E1DA7C641Q24242639-80C0B304-1185-40ED-BBAA-29AA8EB977A7Q24246351-D2342DD2-B903-4C8C-BAFA-0C316FB7AFD9Q24246830-229E3642-0437-4A11-A452-9F33D3AA15CFQ28199921-40DAA349-BD4B-4353-8684-C5C074D958CCQ28740380-E1150D62-8E09-49A3-A105-7319143A67B6Q33966049-C6180F7F-DCF7-4044-A6EA-5DC29B2915B4Q34107639-7231DFEC-E01D-46FC-984E-14A2242D4A17Q35542114-A43F1457-DAB4-41D3-BCA0-D926CABF496FQ36021208-B642273E-FC7E-43D9-AAD2-0183A0859E34Q36070394-4C8CD1A2-FFBE-4DB2-9126-0C2F00123E98Q36680793-4423965B-8B50-4ED7-9FCA-0F0408767456Q37008843-0605E49C-D63F-416D-8ED5-F2640DB41459Q37884498-F462C842-ABB0-4534-9C68-543936EF7DAAQ40560519-04B814EB-5B18-494B-AAE2-7130713B8B95Q40853965-CFA82481-28F6-4B30-AD7A-67E7584632C7Q57786170-6D5128E6-F15B-436F-801C-9BCB064D7040
P2860
Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Reduction in fever and symptom ...... nt with aspirin or amantadine.
@ast
Reduction in fever and symptom ...... nt with aspirin or amantadine.
@en
type
label
Reduction in fever and symptom ...... nt with aspirin or amantadine.
@ast
Reduction in fever and symptom ...... nt with aspirin or amantadine.
@en
prefLabel
Reduction in fever and symptom ...... nt with aspirin or amantadine.
@ast
Reduction in fever and symptom ...... nt with aspirin or amantadine.
@en
P2093
P2860
P356
P1476
Reduction in fever and symptom ...... nt with aspirin or amantadine.
@en
P2093
R G Douglas
S W Younkin
P2860
P304
P356
10.1128/AAC.23.4.577
P407
P577
1983-04-01T00:00:00Z